Oncolytics (ONTY) Reports Positve Results from REOLYSIN Phase 2 in Advanced Head, Neck Cancer Patients
Go back to Oncolytics (ONTY) Reports Positve Results from REOLYSIN Phase 2 in Advanced Head, Neck Cancer Patients| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $1.37 | |||
| Open | $0.85 | 52 Week Low | $0.24 | |||
| Day High | $0.85 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 483,914 | |||||
